Pathogenesis of dengue: challenges to molecular biology - PubMed (original) (raw)
Review
. 1988 Jan 29;239(4839):476-81.
doi: 10.1126/science.3277268.
Affiliations
- PMID: 3277268
- DOI: 10.1126/science.3277268
Review
Pathogenesis of dengue: challenges to molecular biology
S B Halstead. Science. 1988.
Abstract
Dengue viruses occur as four antigenically related but distinct serotypes transmitted to humans by Aedes aegypti mosquitoes. These viruses generally cause a benign syndrome, dengue fever, in the American and African tropics, and a severe syndrome, dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS), in Southeast Asian children. This severe syndrome, which recently has also been identified in children infected with the virus in Puerto Rico, is characterized by increased vascular permeability and abnormal hemostasis. It occurs in infants less than 1 year of age born to dengue-immune mothers and in children 1 year and older who are immune to one serotype of dengue virus and are experiencing infection with a second serotype. Dengue viruses replicate in cells of mononuclear phagocyte lineage, and subneutralizing concentrations of dengue antibody enhance dengue virus infection in these cells. This antibody-dependent enhancement of infection regulates dengue disease in human beings, although disease severity may also be controlled genetically, possibly by permitting and restricting the growth of virus in monocytes. Monoclonal antibodies show heterogeneous distribution of antigenic epitopes on dengue viruses. These epitopes serve to regulate disease: when antibodies to shared antigens partially neutralize heterotypic virus, infection and disease are dampened; enhancing antibodies alone result in heightened disease response. Further knowledge of the structure of dengue genomes should permit rapid advances in understanding the pathogenetic mechanisms of dengue.
Similar articles
- The XXth century dengue pandemic: need for surveillance and research.
Halstead SB. Halstead SB. World Health Stat Q. 1992;45(2-3):292-8. World Health Stat Q. 1992. PMID: 1462664 - Dengue outbreak associated with multiple serotypes--Puerto Rico, 1998.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 1998 Nov 13;47(44):952-6. MMWR Morb Mortal Wkly Rep. 1998. PMID: 9832472 - Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade.
Halstead SB. Halstead SB. Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S830-9. doi: 10.1093/clinids/11.supplement_4.s830. Rev Infect Dis. 1989. PMID: 2665015 Review. - Clinical manifestations of dengue hemorrhagic fever in Puerto Rico, 1990-1991. Puerto Rico Association of Epidemiologists.
Rigau-Pérez JG. Rigau-Pérez JG. Rev Panam Salud Publica. 1997 May;1(5):381-8. doi: 10.1590/s1020-49891997000500007. Rev Panam Salud Publica. 1997. PMID: 9180059 Review. - Dengue in Puerto Rico, 1977: public health response to characterize and control an epidemic of multiple serotypes.
Morens DM, Rigau-Pérez JG, López-Correa RH, Moore CG, Ruiz-Tibén EE, Sather GE, Chiriboga J, Eliason DA, Casta-Velez A, Woodall JP. Morens DM, et al. Am J Trop Med Hyg. 1986 Jan;35(1):197-211. doi: 10.4269/ajtmh.1986.35.197. Am J Trop Med Hyg. 1986. PMID: 3946738
Cited by
- Molecular classification of outcomes from dengue virus -3 infections.
Brasier AR, Zhao Y, Wiktorowicz JE, Spratt HM, Nascimento EJ, Cordeiro MT, Soman KV, Ju H, Recinos A 3rd, Stafford S, Wu Z, Marques ET Jr, Vasilakis N. Brasier AR, et al. J Clin Virol. 2015 Mar;64:97-106. doi: 10.1016/j.jcv.2015.01.011. Epub 2015 Jan 17. J Clin Virol. 2015. PMID: 25728087 Free PMC article. - Liver transcriptomics reveals features of the host response in a mouse model of dengue virus infection.
Zheng W, Yan Q, Li Z, Wang X, Wu P, Liao F, Lao Z, Jiang Y, Liu X, Zhan S, Li G. Zheng W, et al. Front Immunol. 2022 Aug 26;13:892469. doi: 10.3389/fimmu.2022.892469. eCollection 2022. Front Immunol. 2022. PMID: 36091000 Free PMC article. - Comparative expression profiles of midgut genes in dengue virus refractory and susceptible Aedes aegypti across critical period for virus infection.
Chauhan C, Behura SK, Debruyn B, Lovin DD, Harker BW, Gomez-Machorro C, Mori A, Romero-Severson J, Severson DW. Chauhan C, et al. PLoS One. 2012;7(10):e47350. doi: 10.1371/journal.pone.0047350. Epub 2012 Oct 15. PLoS One. 2012. PMID: 23077596 Free PMC article. - The C-terminal 18 Amino Acid Region of Dengue Virus NS5 Regulates its Subcellular Localization and Contains a Conserved Arginine Residue Essential for Infectious Virus Production.
Tay MY, Smith K, Ng IH, Chan KW, Zhao Y, Ooi EE, Lescar J, Luo D, Jans DA, Forwood JK, Vasudevan SG. Tay MY, et al. PLoS Pathog. 2016 Sep 13;12(9):e1005886. doi: 10.1371/journal.ppat.1005886. eCollection 2016 Sep. PLoS Pathog. 2016. PMID: 27622521 Free PMC article. - Convergent antibody signatures in human dengue.
Parameswaran P, Liu Y, Roskin KM, Jackson KK, Dixit VP, Lee JY, Artiles KL, Zompi S, Vargas MJ, Simen BB, Hanczaruk B, McGowan KR, Tariq MA, Pourmand N, Koller D, Balmaseda A, Boyd SD, Harris E, Fire AZ. Parameswaran P, et al. Cell Host Microbe. 2013 Jun 12;13(6):691-700. doi: 10.1016/j.chom.2013.05.008. Cell Host Microbe. 2013. PMID: 23768493 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical